BTK Degradation As a Novel Therapeutic Strategy in Relapsed CNS Lymphoma: Proof of Concept Studies in Intracranial Patient-Derived, Rodent Models. Read more about BTK Degradation As a Novel Therapeutic Strategy in Relapsed CNS Lymphoma: Proof of Concept Studies in Intracranial Patient-Derived, Rodent Models.
BCR::ABL1 kinase N-lobe mutants confer moderate to high degrees of resistance to asciminib. Read more about BCR::ABL1 kinase N-lobe mutants confer moderate to high degrees of resistance to asciminib.
MRD at the end of induction and EFS in T-cell lymphoblastic lymphoma: Children's Oncology Group trial AALL1231. Read more about MRD at the end of induction and EFS in T-cell lymphoblastic lymphoma: Children's Oncology Group trial AALL1231.
Regulatory T cells suppress myeloma-specific immunity during autologous stem cell mobilization and transplantation. Read more about Regulatory T cells suppress myeloma-specific immunity during autologous stem cell mobilization and transplantation.
Old is gold: frontline etoposide for pHLH. Read more about Old is gold: frontline etoposide for pHLH.
Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD. Read more about Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD.
Ablation of Cullin-5 in Primary Human T Cells Improves Tumor Killing and Persistence in BCMA-Targeting CAR-T Cells in a Multiple Myeloma Model. Read more about Ablation of Cullin-5 in Primary Human T Cells Improves Tumor Killing and Persistence in BCMA-Targeting CAR-T Cells in a Multiple Myeloma Model.
Genetic Variants in Canonical Wnt Signaling Pathway Associated with Pediatric ITP. Read more about Genetic Variants in Canonical Wnt Signaling Pathway Associated with Pediatric ITP.
A Phase 3 Study of Eltrombopag Vs. Standard First-Line Management for Newly Diagnosed Immune Thrombocytopenia in Children: Trial in Progress Update. Read more about A Phase 3 Study of Eltrombopag Vs. Standard First-Line Management for Newly Diagnosed Immune Thrombocytopenia in Children: Trial in Progress Update.
